Rapid methods for identifying modifiers of cellular apoptosis activity
AssigneeIdun Pharmaceuticals, Inc.
InventorsLawrence C. Fritz, Jose-Luis Diaz, Robert C. Armstrong, Kevin J. Tomaselli
Life of this patent
Estimating the term…
Loading patent…
AssigneeIdun Pharmaceuticals, Inc.
InventorsLawrence C. Fritz, Jose-Luis Diaz, Robert C. Armstrong, Kevin J. Tomaselli
Estimating the term…
The invention provides a single-well, microscale method of determining the specific apoptotic activity of a cell. In the various embodiments, the method comprising contacting a cell population of greater than about 10,000 to 1×106 cells for a time period of between about 30 minutes and 4 hours with a sufficient volume of medium containing an apoptotic specific diagnostic reagent and a diagnostic accessory reagent so as to cover the cell population, and determining the activity of the apoptotic specific diagnostic reagent. The invention also provides a method of identifying a compound which induces apoptosis. The invention further provides a rapid method of identifying a compound which inhibits apoptosis.
A single-well, micro-scale method of determining the specific apoptotic activity of a cell comprising contacting a cell population with a sufficient volume of medium containing an apoptotic specific diagnostic reagent and a diagnostic accessory reagent so as to cover said cell population, and determining the apoptotic activity of said cell population, wherein said apoptotic specific diagnostic reagent comprises a caspase specific substrate attached to a detectable label.
Dependencies are inferred from the claim text.